Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Cell Host & Microbe
|
December 2, 2025
Cryptococcus exploits delayed microglial activation, and microglial osteopontin/Spp1 impairs peripheral host control
Estefany Y Reyes, Jae Yong, Devon T DiPalma, et al.
Biotechnology Progress
|
February 6, 2025
Rapid bioreactor process optimization and scale-up for production of a measles vector COVID-19 vaccine candidate
David C Hesley, Daniel Spatafore, Jillian Shingler, et al.
Vaccines
|
June 27, 2025
A High-Throughput and Robust Relative Potency Assay Measuring Human Cytomegalovirus Infection in Epithelial Cells for Vaccine Development
Nicole M Smiddy, Nisarg Patel, Matthew C Troutman, et al.
NPJ Vaccines
|
December 22, 2017
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
Fengsheng Li, Daniel C Freed, Aimin Tang, et al.
The Journal of Biological Chemistry
|
May 8, 2015
Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes
John W Loughney, Richard R Rustandi, Dai Wang, et al.
Journal of Virology
|
January 13, 2017
Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex
Sha Ha, Fengsheng Li, Matthew C Troutman, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Cell Host & Microbe
|
December 2, 2025
Cryptococcus exploits delayed microglial activation, and microglial osteopontin/Spp1 impairs peripheral host control
Estefany Y Reyes, Jae Yong, Devon T DiPalma, et al.
Biotechnology Progress
|
February 6, 2025
Rapid bioreactor process optimization and scale-up for production of a measles vector COVID-19 vaccine candidate
David C Hesley, Daniel Spatafore, Jillian Shingler, et al.
Vaccines
|
June 27, 2025
A High-Throughput and Robust Relative Potency Assay Measuring Human Cytomegalovirus Infection in Epithelial Cells for Vaccine Development
Nicole M Smiddy, Nisarg Patel, Matthew C Troutman, et al.
NPJ Vaccines
|
December 22, 2017
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
Fengsheng Li, Daniel C Freed, Aimin Tang, et al.
The Journal of Biological Chemistry
|
May 8, 2015
Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes
John W Loughney, Richard R Rustandi, Dai Wang, et al.
Journal of Virology
|
January 13, 2017
Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex
Sha Ha, Fengsheng Li, Matthew C Troutman, et al.
Page
of 5